Program Overview | Chicago Lymphoma Symposium

17^TH International
Ultmann Chicago Lymphoma Symposium

Virtual Scientific Program

Scientific Program

Presentations will be delivered virtually

Please find the agenda below.

*Agenda subject to change

fri

Friday: August 28, 2020

Session times are in CDT

8:00 AM – 8:15 AM	WELCOME AND INTRODUCTIONS
8:15 AM – 9:30 AM	Mini Symposium on Follicular Lymphoma Molecular Genetics of FL Jessica Okosun, MA, MB BChir, MRCP, FRCPath, PhD Treatment of Newly Diagnosed Disease Brian Hill, MD, PhD Treatment of Relapsed Disease and New Approvals Ian Flinn, MD
9:30 AM – 9:45 AM	BREAK
9:45 AM – 11:00 AM	Mini Symposium on CLL Frontline Treatment – Monotherapy, Double, or Triplet – What to Do? Nitin Jain, MD Biology of CLL at Progression: How Does That Inform Treatment Adrian Wiestner, MD, PhD Richter’s Transformation Deborah Stephens, DO
11:00 AM – 11:15 AM	BREAK
11:15 AM – 12:15 PM	Chicago Hematopathology Multidisciplinary Tumor Board Hematopathologists and a Clinician Review Case Vignettes and Discuss the Interplay in Diagnosis Girish Venkataraman, MD, Mir Alikhan, MD, Shunyou Gong, MD, PhD, Madhu Menon, MD, PhD
12:15 PM – 12:30 PM	BREAK
12:30 PM – 1:30 PM	Keynote Presentation: Pathogenesis and Clinical Course of Aggressive Lymphomas Ari Melnick, MD
1:30 PM	General Session Wrap Up and Adjourn

Nursing Agenda

1:45 – 2:15 PM	Primer on Lymphoma Sonali Smith, MD, FASCO – Co-Chair
2:15 – 3:00 PM	Toxicity of Immunotherapy in Frontline Therapy Side Effects of Immunotherapy Pankti Reid, MD
3:00 PM – 3:15 PM	BREAK
3:15 – 4:00 PM	Practical Approach to Imaging in Patients with Lymphoma Caitlin Murphy, DNP, FNP-BC, AOCNP
4:00 PM – 4:15 PM	BREAK
4:15 – 5:00 PM	Diving into the Diagnosis FISH and Other Laboratory Tests Clinical Complications of these tests for our lymphoma patients Carrie Fitzpatrick, PhD and Jacky Gideon, ANP
5:00 PM	Nursing Session Wrap-Up and Adjourn

sat

Saturday: August 29, 2020

Session times are in CDT

8:00 AM – 8:15 AM	WELCOME AND INTRODUCTIONS
8:15 AM – 9:30 AM	Mini Symposium on R/R DLBCL Cellular Therapy: Is the Efficacy of CAR T-cells Dependent Upon Lymphoma Subtype Krishna Komanduri, MD Immunotherapy Options for DLBCL Beyond CAR T-cells Justin Kline, MD Non-Immunotherapy Options for R/R DLBCL Jason Westin, MD, MS, FACP
9:30 AM – 9:45AM	BREAK
9:45 AM – 11:00 AM	Mini Symposium on T-Cell Lymphoma Systemic therapies for CTCL Neha Mehta-Shah, MD NewlyDiagnosed PTCL Barbara Pro, MD – Co-Chair R/R PTCL PierLuigi Porcu, MD
11:00 AM – 11:15AM	BREAK
11:15 AM – 12:15 PM	Mini Symposium on MCL When to Choose Intensive Induction Therapy Brad Kahl, MD Relapsed MCL: Treatment Options and Sequencing Erel Joffe, MD, MSc
12:15 PM – 12:30 PM	BREAK
12:30 PM – 1:00 PM	Hodgkin Lymphoma: How Best to Incorporate Targeted Therapeutics into 1L Hodgkin Lymphoma Jane Winter, MD
1:00 PM – 1:30 PM	Summary and “Best of IUCLS” Sonali Smith, MD, FASCO, Andrew Evens, DO, MSc, FACP, Barbara Pro, MD
1:30 PM	General Session Wrap-Up and Adjourn